They found that cyclin‐dependent kinase inhibitor 2 A (CDKN2A) deficiency reshapes lipid metabolism, leading to ferroptosis in GBM, highlighting the research value of ferroptosis in GBM.[125]. The gene discussed is CDKN2A; the disease is glioblastoma.